B061

Recent Publications

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS | 

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Riecke, A. ; Robrecht, S. ; Yosifov, D.DKFZ* ; Schneider, C. ; Giza, A. ; Müller, L. ; Vehling-Kaiser, U. ; Eckart, M. J. ; Freier, W. ; Schöttker, B. ; Gaska, T. ; Reiser, M. ; Fink, A.-M. ; Fischer, K. ; Eichhorst, B. F. ; Hallek, M. J. ; Langerbeins, P. ; Stilgenbauer, S. ; Tausch, E.
Ibrutinib in early stage CLL: Genetic risk factors and treatment outcome in the GCLLSG CLL12 trial.
Blood nn, nn (2026) [10.1182/blood.2025032806]2026     Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Yosifov, D. (First author)DKFZ* ; Robrecht, S. ; Giza, A. ; Maity, P. C. ; Riecke, A. ; Schneider, C. ; Jebaraj, B. M. C. ; Dheenadayalan, R. P. ; Jumaa, H. ; Young, M. ; Kumar, M. ; Müller, L. ; Vehling-Kaiser, U. ; Eckart, M. ; Freier, W. ; Schöttker, B. ; Gaska, T. ; Reiser, M. ; Fink, A.-M. ; Fischer, K. ; Eichhorst, B. ; Hallek, M. ; Langerbeins, P. ; Tausch, E. ; Stilgenbauer, S.
IGLV3-21R110 and ibrutinib treatment: Results from the double-blind, randomized, placebo-controlled GCLLSG CLL12 trial in early-stage CLL.
HemaSphere 10(6), e70385 (2026) [10.1002/hem3.70385]2026     Files  Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Qi, J. ; Li, W. ; Dheenadayalan, R. P. ; Yosifov, D.DKFZ* ; Drewes, C. ; Wist, M. ; Wieczorek, M. ; Schmid, V. ; Hobeika, E. ; Gao, X. ; Endres, S. ; Schneider, C. ; Riecke, A. ; Barth, H. ; Gierschik, P. ; Siebert, R. ; Tausch, E. ; Stilgenbauer, S. ; Jebaraj, B. M. C.
PLCG2 exon-skipped variants: insights into their potential role in chronic lymphocytic leukemia
Blood advances 10(15), 5185 - 5198 (2026) [10.1182/bloodadvances.2025019077]2026   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Guo, M. ; Memis, T. ; Ehrmann, A.DKFZ* ; Pittrof, A. ; Baumann, B. ; Ferrante, F. ; Tausch, E. ; Fischer, K. ; Döhner, H. ; Borggrefe, T. ; Stilgenbauer, S. ; Pannicke, U. ; Schwarz, K. ; Mertens, D.DKFZ* ; Oswald, F.
A noncoding mutation in the NOTCH1 gene initiates oncogenic NOTCH signaling via wild-type NICD stabilization in CLL.
Blood 146(16), 1936–1949 (2025) [10.1182/blood.2025028529]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Yosifov, D. (First author)DKFZ* ; Schneider, C. ; Stilgenbauer, S. ; Mertens, D.DKFZ* ; Tausch, E.
Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samples.
BMC Research Notes 18(1), 270 (2025) [10.1186/s13104-025-07348-3]2025     Fulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Ehrmann, A. (First author)DKFZ* ; Quijada-Álamo, M. ; Close, V. (First author)DKFZ* ; Guo, M. ; Carracoi, V. ; Pérez-Carretero, C. ; Corchete, L. A. ; Friedrich, T. ; Giaimo, B. D. ; Yosifov, D.DKFZ* ; Bloehdorn, J. ; Rodríguez-Sánchez, A. ; Tausch, E. ; Schneider, C. ; Döhner, H. ; Kietzmann, T. ; Borggrefe, T. ; Stilgenbauer, S. ; Oswald, F. ; Hernández-Rivas, J.-M. ; Mertens, D. (Last author)DKFZ*
NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL.
Leukemia 39(8), 1892-1904 (2025) [10.1038/s41375-025-02632-4]2025   BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Yosifov, D. (First author)DKFZ* ; Reichenzeller, M. ; Stilgenbauer, S. ; Mertens, D. (Last author)DKFZ*
repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate method.
BMC bioinformatics 25(1), 331 (2024) [10.1186/s12859-024-05954-9]2024     Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Ehrmann, A. (First author)DKFZ* ; Zadro, A. ; Tausch, E. ; Schneider, C. ; Stilgenbauer, S. ; Mertens, D. (Last author)DKFZ*
The NOTCH1 and miR-34a signaling network is affected by TP53 alterations in CLL.
Leukemia and lymphoma 65(13), 1941-1953 (2024) [10.1080/10428194.2024.2392839]2024     Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Rössner, P. (First author)DKFZ* ; Seufert, I. ; Chapaprieta, V. ; Jayabalan, R.DKFZ* ; Briesch, H.DKFZ* ; Massoni-Badosa, R.DKFZ* ; Boskovic, P.DKFZ* ; Beckendorff, J. ; Roider, T. ; Arseni, L.DKFZ* ; Coelho, M.DKFZ* ; Chakraborty, S. ; Vaca, A. ; Sivina, M. ; Muckenhuber, M.DKFZ* ; Rodriguez-Rodriguez, S. ; Bonato, A. ; Herbst, S. A. ; Zapatka, M.DKFZ* ; Sun, C. ; Kretzmer, H. ; Naake, T. ; Bruch, P.-M. ; Czernilofsky, F. ; Ten Hacken, E. ; Schneider, M.DKFZ* ; Helm, D.DKFZ* ; Yosifov, D.DKFZ* ; Kauer, J. ; Danilov, A. V. ; Bewarder, M. ; Heyne, K. ; Schneider, C. ; Stilgenbauer, S. ; Wiestner, A. ; Mallm, J.-P.DKFZ* ; Burger, J. A. ; Efremov, D. G. ; Lichter, P.DKFZ* ; Dietrich, S. ; Martín-Subero, J. I. ; Rippe, K.DKFZ* ; Seiffert, M. (Last author)DKFZ*
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.
Blood 144(5), 510-524 (2024) [10.1182/blood.2023021990]2024     Files BibTeX | EndNote: XML, Text | RIS

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article Qi, J. ; Endres, S. ; Yosifov, D. Y. ; Tausch, E. ; Dheenadayalan, R. P. ; Gao, X. ; Müller, A. ; Schneider, C. ; Mertens, D.DKFZ* ; Gierschik, P. ; Wist, M. ; Jebaraj, B. M. C. ; Stilgenbauer, S.
Acquired BTK mutations associated with resistance to non-covalent BTK inhibitors.
Blood advances 7(19), 5698-5702 (2023) [10.1182/bloodadvances.2022008955]2023   BibTeX | EndNote: XML, Text | RIS

All known publications ...
Download: BibTeX | EndNote XML,  Text | RIS |